Wang, M., Zhang, Y., Jia, B., Wang, C., Xu, J., Wang, S., Zhao, X., Li, Y., Wang, C., Zhang, H., Wang, X., Yuan, S. (2026). Adebrelimab in combination with anlotinib and chemotherapy as neoadjuvant therapy for resectable stage II-III non–small cell lung cancer (NSCLC): A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20073